Trials / Unknown
UnknownNCT00910130
Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether Retinol binding protein 4 has a role in insulin resistance development in patients suffering from end stage renal disease on hemodialysis.
Conditions
Timeline
- Start date
- 2008-07-01
- First posted
- 2009-05-29
- Last updated
- 2009-05-29
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00910130. Inclusion in this directory is not an endorsement.